Josel D. Ruiz

1.4k total citations
16 papers, 155 citations indexed

About

Josel D. Ruiz is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Josel D. Ruiz has authored 16 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in Josel D. Ruiz's work include Hematopoietic Stem Cell Transplantation (9 papers), CAR-T cell therapy research (5 papers) and Acute Myeloid Leukemia Research (3 papers). Josel D. Ruiz is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), CAR-T cell therapy research (5 papers) and Acute Myeloid Leukemia Research (3 papers). Josel D. Ruiz collaborates with scholars based in United States, France and Italy. Josel D. Ruiz's co-authors include Molly Maloy, Miguel‐Angel Perales, Victoria Gutgarts, Edgar A. Jaimes, Junting Zheng, Martina Pennisi, Tania Jain, Michael Scordo, Sergio Giralt and Sean M. Devlin and has published in prestigious journals such as Blood, Clinical Pharmacokinetics and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Josel D. Ruiz

15 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josel D. Ruiz United States 5 101 45 31 24 19 16 155
Victoria Gutgarts United States 8 93 0.9× 32 0.7× 26 0.8× 25 1.0× 12 0.6× 22 179
Ana Carla Oliveira Spain 8 45 0.4× 13 0.3× 96 3.1× 7 0.3× 9 0.5× 25 175
Yanzhi Song China 7 200 2.0× 28 0.6× 12 0.4× 60 2.5× 38 2.0× 21 244
Caroline Dudreuilh United Kingdom 8 71 0.7× 11 0.2× 21 0.7× 21 0.9× 6 0.3× 17 230
Doured Daghistani United States 7 22 0.2× 38 0.8× 5 0.2× 18 0.8× 2 0.1× 15 198
Hazim Ababneh United States 6 71 0.7× 4 0.1× 21 0.7× 11 0.5× 23 1.2× 25 105
Marie Lundberg Finland 12 76 0.8× 5 0.1× 9 0.3× 6 0.3× 9 0.5× 41 293
K. Li China 6 127 1.3× 9 0.2× 10 0.3× 3 0.1× 7 0.4× 29 204
Tito Roccia United States 7 49 0.5× 73 1.6× 3 0.1× 6 0.3× 5 0.3× 25 150
Thomas Doerr United States 7 141 1.4× 113 2.5× 4 0.1× 15 0.6× 8 0.4× 13 335

Countries citing papers authored by Josel D. Ruiz

Since Specialization
Citations

This map shows the geographic impact of Josel D. Ruiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josel D. Ruiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josel D. Ruiz more than expected).

Fields of papers citing papers by Josel D. Ruiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josel D. Ruiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josel D. Ruiz. The network helps show where Josel D. Ruiz may publish in the future.

Co-authorship network of co-authors of Josel D. Ruiz

This figure shows the co-authorship network connecting the top 25 collaborators of Josel D. Ruiz. A scholar is included among the top collaborators of Josel D. Ruiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josel D. Ruiz. Josel D. Ruiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wong, Phillip, Jessica Flynn, Caleb Ho, et al.. (2025). Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients. Journal of Geriatric Oncology. 16(8). 102346–102346.
2.
Dahi, Parastoo B., Jessica Flynn, Sean M. Devlin, et al.. (2023). Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma. Leukemia & lymphoma. 64(14). 2279–2285. 1 indexed citations
3.
Scordo, Michael, Leah Gilbert, Jessica Flynn, et al.. (2022). Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation. Blood Advances. 7(8). 1536–1544. 4 indexed citations
4.
Lin, Andrew, Samantha Brown, Molly Maloy, et al.. (2022). Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation. Leukemia & lymphoma. 63(7). 1686–1693. 2 indexed citations
5.
Dahi, Parastoo B., Andrew Lin, Michael Scordo, et al.. (2022). Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(8). 485.e1–485.e6. 1 indexed citations
6.
Sánchez‐Escamilla, Miriam, Sean M. Devlin, Molly Maloy, et al.. (2022). Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Advances. 6(22). 5898–5907. 12 indexed citations
7.
Shah, Nishi, Ana Alarcón Tomás, Josel D. Ruiz, et al.. (2021). High Rates of Residual Vaccine Titers at 1-Year Post CD19 Chimeric Antigen Receptor T Cell Therapy. Transplantation and Cellular Therapy. 27(3). S355–S355. 3 indexed citations
8.
Reingold, Rachel, Jilliana Monnier, Marco Ardigò, et al.. (2021). Real-Time Reflectance Confocal Microscopy of Cutaneous Graft-versus-Host Disease Correlates with Histopathology. Transplantation and Cellular Therapy. 28(1). 51.e1–51.e14. 2 indexed citations
9.
Gutgarts, Victoria, Junting Zheng, Molly Maloy, et al.. (2021). Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Journal of the American Society of Nephrology. 16(9). 1318–1327. 20 indexed citations
10.
Shah, Gunjan L., Jaap Jan Boelens, Dean Carlow, et al.. (2021). Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens. Clinical Pharmacokinetics. 61(4). 553–563. 7 indexed citations
11.
Dahi, Parastoo B., Sean M. Devlin, Josel D. Ruiz, et al.. (2021). Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma. Blood Advances. 5(12). 2608–2618. 32 indexed citations
12.
Gutgarts, Victoria, Tania Jain, Junting Zheng, et al.. (2020). Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery. Biology of Blood and Marrow Transplantation. 26(6). 1071–1076. 66 indexed citations
13.
Jain, Tania, Andrea Knežević, Martina Pennisi, et al.. (2020). Hematopoietic Recovery Following Chimeric Antigen Receptor T Cell (CAR T) Therapy in Hematological Malignancies. Biology of Blood and Marrow Transplantation. 26(3). S63–S64. 1 indexed citations
14.
Shah, Gunjan L., Raymond E. Baser, Michael Scordo, et al.. (2020). Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma. Biology of Blood and Marrow Transplantation. 26(11). 2040–2046. 1 indexed citations
15.
Gutgarts, Victoria, Tania Jain, Junting Zheng, et al.. (2020). Renal Effects and Recovery in Patients Receiving Chimeric Antigen Receptor T Cell Therapy. Biology of Blood and Marrow Transplantation. 26(3). S267–S267. 1 indexed citations
16.
Imber, Brandon S., Miguel‐Angel Perales, Jessica Flynn, et al.. (2020). Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas. Blood. 136(Supplement 1). 1–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria Gutgarts Breakdown of academic impact, for papers by Ana Carla Oliveira Breakdown of academic impact, for papers by Yanzhi Song Breakdown of academic impact, for papers by Caroline Dudreuilh Breakdown of academic impact, for papers by Doured Daghistani Breakdown of academic impact, for papers by Hazim Ababneh Breakdown of academic impact, for papers by Marie Lundberg Breakdown of academic impact, for papers by K. Li Breakdown of academic impact, for papers by Tito Roccia Breakdown of academic impact, for papers by Thomas Doerr
Rankless by CCL
2026